Clindesse is a prescription brand containing clindamycin phosphate 2% vaginal cream for treatment of bacterial vaginosis in the population described by its FDA label. It is supplied in a single-dose prefilled applicator, which is an essential part of its identity. A retail listing for generic clindamycin 2% vaginal cream may refer to a different, multi-day formulation rather than the same prefilled unit. Matching the product name alone cannot resolve that distinction.
The product is not oral clindamycin and not metronidazole vaginal gel. Its active ingredient and vehicle are different, and the labeled instructions include important warnings about diarrhea and the reliability of certain barrier contraceptives. Because the dosing presentation is distinct, a prescriber and pharmacist must resolve any proposed substitution rather than assume all 2% creams have an identical course.
The Nuvessa versus Clindesse comparison contrasts two single-dose products with different ingredients and vehicles. The standard clindamycin vaginal cream guide covers the conventional multi-day family. This page is specifically about purchasing the labeled Clindesse brand package and verifying responsible U.S. pharmacy dispensing.
The following matrix is designed specifically for Clindesse clindamycin phosphate 2% vaginal cream rather than for every product with a similar ingredient name. It separates the prescription's precise dosage form, route and product-status questions from merchandising language. The comparison does not suggest that another brand, route or concentration can be substituted without pharmacist and prescriber verification.
Pay particular attention to single prefilled disposable applicator: this feature determines whether a displayed medicine matches the actual clinical order. A misleading search result can confuse conventional multi-day generic clindamycin 2% vaginal cream with the intended Clindesse clindamycin phosphate 2% vaginal cream. Product equivalence, if applicable, depends on the FDA reference and state pharmacy rules, while treatment changes require clinical authorization.
| Product element | Clindesse brand | Conventional clindamycin cream |
|---|---|---|
| Active ingredient | Clindamycin phosphate | Usually clindamycin phosphate |
| Strength | 2% vaginal cream | Commonly 2% vaginal cream |
| Applicator | Single prefilled disposable applicator | Often tube with multiple applicators |
| Course format | Single-dose label | Common multi-day course |
| Label population | BV in nonpregnant women | Product-specific labeled populations |
| Barrier advice | Specific post-treatment condom/diaphragm caution | Different label-specific counseling |
| Pharmacy decision | Confirm Clindesse unit packaging | Not assumed to be an equivalent brand substitution |
Clindesse is supplied as one prefilled, single-use applicator that delivers approximately 5 g of 2% cream. This is not a tube requiring several applicators to complete a conventional seven-day cream regimen. A pharmacy result showing a generic 2% cream tube should be treated as a different presentation until prescriber and pharmacist confirm how it relates to the specific prescription.
Ask the dispenser whether the carton contains the complete labeled single-dose product and whether the instructions are current. Do not transfer cream between applicators, try to divide an applicator or substitute an ordinary vaginal cream based only on the percentage printed on the label.
Clindesse is a mineral-oil-containing, single-dose 2% clindamycin vaginal cream. Its current FDA label advises against condoms and vaginal contraceptive diaphragms during treatment and for five days afterward because barrier reliability can be reduced. This is a product-specific warning and should not be replaced with the 72-hour interval specified for clindamycin ovules or the different polyurethane-condom warning associated with Xaciato gel.
When a patient compares a one-dose BV product with another, the active ingredient, vehicle and labeled precautions need to be read together. Clindesse and Nuvessa have different active drugs; Clindesse and Xaciato have different vehicles despite both containing clindamycin. A pharmacy must verify the prescribed item and its applicator before dispensing rather than assuming all one-dose vaginal preparations have identical administration or follow-up requirements.
The official Clindesse label indicates use for bacterial vaginosis in nonpregnant women. The clinician must assess symptoms, pregnancy status when relevant and the possibility of other causes of vaginal discomfort. A treatment selected for yeast infection, trichomoniasis or other infections cannot be assumed appropriate for BV merely because products are stocked in the same pharmacy category.
The BV prescription overview distinguishes relevant drugs and routes. Patients with recurrent symptoms or failure of a previous treatment may require testing and a revised plan instead of repeatedly buying the same single-dose brand.
Clindesse labeling advises against use of barrier contraceptives such as condoms or vaginal contraceptive diaphragms concurrently and for five days after treatment, because reliability may be affected. This is not a rule to generalize automatically to every vaginal clindamycin formulation. The product-specific warning is a material part of choosing and dispensing the cream.
Counseling should also address a history of colitis, inflammatory bowel disease and serious antibiotic-associated diarrhea where relevant. Clindamycin can have systemic adverse effects even when used vaginally. Severe diarrhea or other concerning symptoms warrant medical assessment, not an additional application of cream.
Xaciato is another brand using clindamycin for BV, but its dosage form is vaginal gel with a tube and user-filled applicator, not Clindesse's prefilled cream device. A shared 2% concentration and single administration do not justify describing them as the same product or swapping their application instructions.
The Xaciato brand guide explains its distinct package and polyurethane condom warning. These differences matter in the real world: a buyer may find both names on a search page but must still obtain the exact product prescribed.
The prescription should identify Clindesse vaginal cream 2% and the intended single-dose package. The pharmacist verifies the order, the patient, relevant contraindications and the current product label before dispensing. A promised delivery date or product photo does not establish the actual packaging received.
If the pharmacy proposes a generic clindamycin 2% tube or another vaginal product, the patient should ask whether the prescriber has authorized a different regimen. Even a therapeutically reasonable alternative is not necessarily a regulatory generic equivalent to Clindesse.
A branded single-dose applicator has a different unit of purchase from a full tube used across several nights. Insurance formularies, copayments and prior authorization may therefore require separate verification. An evergreen article cannot state a reliable price without the patient's pharmacy and plan details.
The most useful request is an itemized confirmation of the prescribed Clindesse package, current patient payment and any permitted alternatives if the brand is not covered. Cost concerns should go back to the pharmacist and prescriber rather than lead to silent substitution.
A Clindesse prescription must be matched to the single prefilled 2% clindamycin phosphate cream applicator. The patient should not receive an ordinary multi-dose tube and instructions for one application unless the prescriber has reviewed and authorized that specific change. The carton, directions, route, complete dose and applicator design all contribute to product identity.
The FDA label describes a single-use application of approximately 5 g of cream. Before paying, ask the pharmacist to confirm the brand requested, whether the prescribed unit is available, and whether any proposed alternative would require a new order. A one-dose Xaciato clindamycin vaginal gel or a Nuvessa metronidazole gel is a separate medicine, not another name for Clindesse.
An online pharmacy offering Clindesse should require a valid U.S. prescription and provide verifiable state pharmacy licensing and pharmacist contact information. A listing with the correct brand image but no exact 2% vaginal cream presentation, no dispensing pharmacy identity or a promise of antibiotic purchase without a prescription is not a reliable basis for an order.
Ask whether shipment includes the original labeled single-dose applicator and patient instructions. The cream contains mineral oil; its FDA label cautions against condoms and vaginal contraceptive diaphragms concurrently or for five days after treatment. Delivery timing must not cause a patient to use a different clindamycin product or improvise a course.
The meaningful price unit for Clindesse is its complete single-dose prefilled applicator, not the cost per gram of a standard seven-day clindamycin cream tube. Compare any quote against that exact item, insurer restrictions and whether a pharmacy can actually supply the written prescription. An FDA label or searchable NDC does not confirm local stock.
If insurance rejects a brand claim, ask the prescriber whether a different FDA-labeled BV regimen is clinically appropriate, then obtain a separate quote for the new prescription. Distinguish an insurer-preferred alternative from an FDA-rated generic equivalent; the same active ingredient and 2% strength alone do not prove pharmaceutical interchangeability.
Yes. Its FDA label describes one prefilled applicator containing 2% clindamycin vaginal cream.
Not automatically. Conventional cream is generally prescribed as a multi-day course with different packaging.
No. It is a prescription vaginal antibacterial product.
It is labeled for BV, not as a general trichomoniasis treatment.
Clindesse labeling cautions against condoms and vaginal diaphragms during treatment and for five days afterward.
These are separate cream and gel products with different devices and warnings; ask the prescriber before a change.
Ask whether the new product and course were authorized; a generic tube is not the same prefilled branded device.
Clindamycin products can cause serious antibiotic-associated diarrhea; the label includes important contraindications and warnings.
The label indicates BV in nonpregnant women. Pregnancy requires individual clinical assessment of appropriate alternatives.
Use a licensed pharmacy requiring a valid prescription and verify the original prefilled package and label.